Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Phase II study of everolimus and octreotide LAR in patients with nonfunctioning gastrointestinal neuroendocrine tumors: The GETNE1003_EVERLAR study. Have a read: https://www.m3india.in/contents/journal/phase-ii-study-of-everolimus-and-octreotide-lar?utm_campaign=unset&utm_medium=share&utm_source=ref_wa